abstract objective: the aim of this study was to screen for and quantify the neurotoxic amino acid beta-n-methylamino-l-alanine (bmaa) in a cohort of autopsy specimens taken from alzheimer's disease (ad), amyotrophic lateral sclerosis (als), huntington's disease (hd), and non-neurological controls.